An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants
Bruce NmeziiD, Guillermo Rodríguez BeyiD, Talia DeFrancesco OranburgiD, Kseniia DudnykiD, Santana M. LardoiD, Nathan Herdman, Anastasia M. JackoiD, Sandy Rubio, Emanuel Loeza‐AlcoceriD, Julia KofleriD, Dongkyeong Kim, Julia Rankin, Emma C. KivuvaiD, Nicholas J. Gutowski, Katherine R. SchoniD, Jelle van den AmeeleiD, Patrick Francis ChinneryiD, Sérgio Bernardo de SousaiD, Filipe PalavraiD, Camilo ToroiD, Filippo Pinto e VairoiD, Jonas Alex Morales SauteiD, Lisa A. PaniD, Murad A. AlturkustaniiD, Robert R HammondiD, , Quasar Saleem PadiathiD
Abstract
The role of non-coding regulatory elements and how they might contribute to tissue type specificity of disease phenotypes is poorly understood. Autosomal Dominant Leukodystrophy (ADLD) is a fatal, adult-onset, neurological disorder that is characterized by extensive CNS demyelination. Most cases of ADLD are caused by tandem genomic duplications involving the lamin B1 gene (LMNB1) while a small subset are caused by genomic deletions upstream of the gene. Utilizing data from recently identified families that carry LMNB1 gene duplications but do not exhibit demyelination, ADLD patient tissues, CRISPR modified cell lines and mouse models, we have identified a novel silencer element that is lost in ADLD patients and that specifically targets overexpression to oligodendrocytes. This element consists of CTCF binding sites that mediate three-dimensional chromatin looping involving the LMNB1 and the recruitment of the PRC2 repressor complex. Loss of the silencer element in ADLD identifies a previously unknown role for silencer elements in tissue specificity and disease causation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 2.10
- Field percentile
- top 14%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional validation of allele-specific LMNB1 silencing in patient-derived astrocytes as a therapeutic option for Autosomal Dominant Leukodystrophy
Martina Lorenzati, Arianna Contato, … Annalisa Buffo·bioRxiv·Sep 15, 2026
- Multi-omic approach to identify phenotypic modifiers underlying cerebral demyelination in X-linked adrenoleukodystrophy
Phillip A. Richmond, Frans M. van der Kloet, … Clara van Karnebeek·Frontiers in Cell and Developmental BiologyPeer-reviewed·Jun 25, 2020
- Nuclear BIN1 isoforms regulate c-Myc-mediated cell cycle control in oligodendrocytes
Iris Wai-Ting Ma, Gerald Wai‐Yeung Cheng, … Kai‐Hei Tse·bioRxiv·Sep 30, 2025
- A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis
Ezzat Hashemi, Isha N. Srivastava, … Keith P. van Haren·Annals of NeurologyPeer-reviewed·Oct 28, 2024
- Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy
Jeremy Y. Huang, Brian Freed, … Can Kayatekin·iSciencePeer-reviewed·Jul 31, 2025
- Oligodendrocytes depend on MCL-1 to prevent spontaneous apoptosis and white matter degeneration
Abigail H. Cleveland, Alejandra I. Romero-Morales, … Timothy R. Gershon·Cell Death and DiseasePeer-reviewed·Dec 6, 2021